Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.
Thaisa CottonMarvin J FritzlerMay Yee ChoiBoyang ZhengOmid Zahedi NiakiChristian A PineauLuck LukusaSasha BernatskyPublished in: Lupus (2022)
Baseline myositis-related biomarkers were highly associated with ILD/myositis incidence. This is the first identification of biomarker phenotypes with ILD/myositis risk in SLE.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- systemic lupus erythematosus
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- disease activity
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- coronavirus disease
- respiratory syndrome coronavirus